Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: May 30, 2007
Last updated: September 17, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)